The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.
Carbon monoxide is a colorless and odorless poisonous gas. It is produced when anything that contains carbon is burned. It is ...
Lung cancer is the most common cancer that occurs when cells in the lungs tend to divide uncontrollably, causing tumours. The ...
This deal combines Spire's patient monitoring technology with Wellinks' virtual-led cardiopulmonary care approach, creating ...
The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic ...
The following is a summary of "Emergent Pericardial Window in a Patient with Sarcoidosis-like Interstitial Lung Disease, COPD ...
The following is a summary of “Vancomycin-resistant Enterococcus (VRE) Pneumonia in a Patient With Advanced Chronic ...
The mission of Blessed Home Health Care in Oregon is to provide health services to patients in the comfort and dignity of ...
Hurricane Helene's massive rains and flooding is a major health and safety risk for residents exposed to potential ...
Zacks.com on MSN18h
Sanofi, Regeneron's Dupixent Gets FDA Approval for COPDSanofi SNY and partner Regeneron REGN announced that the FDA has approved their blockbuster drug, Dupixent, for its sixth ...
The FDA has approved Dupixent (dupilumab) as an add-on therapy for adults with poorly controlled COPD, especially those with ...
In adults with undiagnosed respiratory symptoms, dyspnea impact was worse in those with PRISm vs undiagnosed asthma or COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback